← Back to Search

HIPEC for Bladder Cancer

N/A
Waitlist Available
Led By Douglas S Scherr, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This trial is testing a new way to give chemotherapy to people with bladder cancer that has spread to their muscles. The study will look at how well the treatment works and if it has any side effects.

Eligible Conditions
  • Bladder Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Treatment toxicity

Trial Design

1Treatment groups
Experimental Treatment
Group I: HIPEC after Radical CystectomyExperimental Treatment1 Intervention
After completion of radical cystectomy, HIPEC will be administered using closed abdomen technique for a duration of 60 minutes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HIPEC
2014
Completed Phase 3
~230

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,059 Previous Clinical Trials
1,316,136 Total Patients Enrolled
Douglas S Scherr, MDPrincipal InvestigatorWeill Cornell Medicine - New York Presbyterian Hospital
2 Previous Clinical Trials
28 Total Patients Enrolled
~1 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top